Pluri Inc. Files 10-Q for Quarterly Period Ended March 31, 2024

TL;DR

<b>Pluri Inc. has filed its quarterly report (10-Q) for the period ending March 31, 2024, detailing its financial status and operations.</b>

AI Summary

Pluri Inc. (PLUR) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Pluri Inc. filed a 10-Q report for the quarterly period ended March 31, 2024. The company is registered in Nevada with IRS number 980351734. Its principal executive offices are located at Matam Advanced Technology Park, Building No. 5, Haifa, Israel. Pluri Inc.'s common shares trade on The Nasdaq Capital Market under the symbol PLUR. The company has elected to be treated as a smaller reporting company and a non-accelerated filer.

Why It Matters

For investors and stakeholders tracking Pluri Inc., this filing contains several important signals. This filing provides investors with the latest financial performance and operational updates for Pluri Inc. for the specified quarter. As a smaller reporting company, this 10-Q offers insights into the company's financial health and strategic direction.

Risk Assessment

Risk Level: low — Pluri Inc. shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain immediate material changes or significant financial distress indicators, suggesting a low level of immediate risk from this specific document.

Analyst Insight

Review the detailed financial statements and management's discussion and analysis within the 10-Q to understand Pluri Inc.'s current operational performance and future outlook.

Key Numbers

• 2024-03-31 — Quarter End Date (Period for the 10-Q filing)
• 001-31392 — Commission File Number (SEC registration number)
• 2024-05-09 — Filing Date (Date the 10-Q was filed)

Key Players & Entities

• Pluri Inc. (company) — Registrant
• March 31, 2024 (date) — Quarterly period ended
• Nevada (jurisdiction) — State of incorporation
• 980351734 (identifier) — I.R.S. Employer Identification No.
• Matam Advanced Technology Park (location) — Address of principal executive offices
• Haifa (location) — City of principal executive offices
• PLUR (ticker) — Trading Symbol
• The Nasdaq Capital Market (exchange) — Name of each exchange on which registered

FAQ

Industry Context

Pluri Inc. operates in the biotechnology sector, focusing on the development and commercialization of cell-based therapeutics.

Regulatory Implications

The filing is made under Section 13 or 15(d) of the Securities Exchange Act of 1934, requiring regular reporting of financial and operational information.

What Investors Should Do

1. Analyze the financial statements for revenue, expenses, and cash flow.
2. Review the Management's Discussion and Analysis of Financial Condition and Results of Operations for strategic insights.
3. Check for any new risk factors or updates to existing ones disclosed in the filing.

Key Dates

• 2024-03-31: Quarterly Period End — End date for the financial reporting period covered by the 10-Q.
• 2024-05-09: Filing Date — Date Pluri Inc. submitted its 10-Q to the SEC.

Year-Over-Year Comparison

This is the 10-Q filing for the quarter ended March 31, 2024, following previous filings for the fiscal year 2024.

Key Financial Figures

• $0.00001 — ch registered Common Shares, par value $0.00001 PLUR The Nasdaq Capital Market Securi
• $1 — ty $ 36,390 $ 50,797 (*) Less than $1 (**) See note 1d regarding reverse sto

Filing Documents

• ea0205163-10q_pluriinc.htm (10-Q) — 517KB
• ea020516301ex3-3_pluriinc.htm (EX-3.3) — 22KB
• ea020516301ex3-4_pluriinc.htm (EX-3.4) — 22KB
• ea020516301ex31-1_pluriinc.htm (EX-31.1) — 10KB
• ea020516301ex31-2_pluriinc.htm (EX-31.2) — 11KB
• ea020516301ex32-1_pluriinc.htm (EX-32.1) — 3KB
• ea020516301ex32-2_pluriinc.htm (EX-32.2) — 4KB
• 0001213900-24-041274.txt (&nbsp;) — 3103KB
• plur-20240331.xsd (EX-101.SCH) — 29KB
• plur-20240331_cal.xml (EX-101.CAL) — 27KB
• plur-20240331_def.xml (EX-101.DEF) — 143KB
• plur-20240331_lab.xml (EX-101.LAB) — 310KB
• plur-20240331_pre.xml (EX-101.PRE) — 150KB
• ea0205163-10q_pluriinc_htm.xml (XML) — 325KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS As of March 31, 2024 U.S. DOLLARS IN THOUSANDS (Unaudited) INDEX Page Interim Condensed Consolidated Balance Sheets 1-2 Interim Condensed Consolidated Statements of Operations 3 Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) 4-5 Interim Condensed Consolidated Statements of Cash Flows 6-7 Notes to Interim Condensed Consolidated Financial Statements 8-14 i PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) U.S. Dollars in thousands (except share and per share data) Note March 31, 2024 June 30, 2023 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 7,081 $ 5,360 Short-term bank deposits 18,926 34,811 Restricted cash 273 269 Prepaid expenses and other current assets 1,087 969 Total current assets 27,367 41,409 LONG-TERM ASSETS: Restricted bank deposits 637 627 Severance pay fund 459 439 Property and equipment, net 769 688 Operating lease right-of-use asset 7,151 7,633 Long-term deposit and other long-term assets 7 1 Total long-term assets 9,023 9,388 Total assets $ 36,390 $ 50,797 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 1 PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) U.S. Dollars in thousands (except share and per share data) Note March 31, 2024 June 30, 2023 LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) CURRENT LIABILITIES Trade payables $ 1,030 $ 1,812 Accrued expenses 958 1,209 Operating lease liability 675 627 Accrued vacation and recuperation 810 873 Advances from customers 101 7 Other accounts payable 952 1,093 Total current liabilities 4,526 5,621 LONG-TERM LIABILITIES Accrued severance pay 611 598 Operating lease liability 5,343 5,748 Loan from the European Investment Bank ("EIB")

View Full Filing

View this 10-Q filing on SEC EDGAR